Verismo Therapeutics Employee Directory
Biotechnology ResearchPennsylvania, United States11-50 Employees
Verismo Therapeutics is a biotechnology research company focused on developing novel chimeric antigen receptor (CAR) therapies to enhance T-cell–based immunotherapy for cancer, with an emphasis on solid tumors and B-cell–related disorders. Its core approach involves engineered CARs designed to more closely reflect natural multichain receptor structures, aiming to improve the effectiveness of cell-based treatments beyond current second-generation CAR designs. The company’s lead programs center on SynKIR-T cells, which integrate these multichain receptors into T cells to target aggressive malignancies more effectively in preclinical models. Verismo operates from Philadelphia, Pennsylvania, and positions itself within the cutting-edge area of cellular immunotherapy research, pursuing translational advances toward clinical evaluation.